Skip to main content
. 2013 Feb 22;8(2):e56706. doi: 10.1371/journal.pone.0056706

Table 1. Patient characteristics.

Characteristics Proven/Probable CNS IA*(n = 8) Possible/CNS IA*(n = 22) No CNS IA (n = 25)
Age (median, range) 38 (4–82) 42 (8–68) 55 (0–73)
Gender (female/male) 4/4 11/11 14/11
Underlying disease
AML 1 8 3
ALL 4 4 7
NHL 2 4 10
AIHA 0 0 1
MPN 0 1 0
MDS 0 1 0
Aplastic Anemia 0 1 0
CVID 0 1 0
Solid Tumor 0 0 1
Other 1 2 3
Among them patients after/with
Allo-HSCT 3 9 2
Auto-HSCT 0 1 0
 HIV infection 0 1 0
*

according to 2008 EORTC/MSG Criteria modified by Schwartz et al.

AML: acute myeloid leukemia; ALL acute lymphoblastic leukemia; NHL Non-Hodgkińs-Lymphoma; MDS: Myelodysplastic Syndrome; MPN: myeloproliferative neoplasia; Allo-HSCT: allogeneic hematopoietic stem cell transplantation; Auto-HSCT: autologous hematopoietic stem cell transplantation; AIHA: Autoimmunehemolytic anemia; CVID : common variable immunodeficiency syndrome; other: Primary chronic polyarthritis, HIV infection, sarcoidosis, miliary tuberculosis, bacterial meningitis.